The expression and release of chemerin increases in the placenta of women with preeclampsia and are positively correlated with the ratio of soluble Fms-like tyrosine kinase-1 (sFlt-1) to placental growth factor (PlGF), a commonly used biomarker of preeclampsia. The gene discussed is RARRES2; the disease is preeclampsia.